The body's immune system can turn against CAR T cell therapy for diffuse midline glioma
Original title: Anti-CAR Immunity Drives Acquired Therapeutic Resistance to GD2-CAR T Cell Therapy in Diffuse Midline Glioma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This looked at blood and spinal fluid from patients in a trial to explain why a treatment stops working, not to test a new treatment.
The short version
Researchers found one reason a new cell therapy for this brain tumor stops working: the patient's own immune system attacks the treatment.
What was studied. Researchers studied patients with H3K27M diffuse midline glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary who were getting GD2-CAR T cell therapy in a clinical trial. They tested the patients' spinal fluid and blood over time to see what the immune cells were doing.
What they found. The CAR T cells did not last long in the spinal fluid. The patients' own immune cells, both T cells and B cells, reacted against parts of the CAR T cells. The body made antibodies that stuck to the CAR T cells and blocked them from killing tumor cells. When these antibodies showed up in the blood, the tumor often started growing again, and fewer CAR T cells were left in the blood.
What this means, and what it doesn't
What it could mean: It gives doctors a possible reason why this therapy helps some patients for a while and then stops helping. If researchers can keep the immune system from attacking the treatment, the treatment might last longer. That work has not been done yet.
What it doesn't mean: This does not mean there is a new or better treatment available. GD2-CAR T cell therapy itself is still being tested in a trial and is not standard care. This study only explains a problem. It does not fix it, and it is not a cure. Nothing here changes the treatment your doctor can offer you today.
Source: PubMed, July 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.